CD1D and ovarian cancer: When murine CD1d+ fibroblasts were treated with human ascites from ovarian cancer patients, CD1d-dependent iNKT cell activation was markedly reduced, suggesting that a soluble factor released from ovarian tumors could affect CD1d-dependent activation (75).